Polygenic score
Influential genes: CASC11,TACC3
CASC11 can play crucial roles in the regulation of gene expression. Studies suggest that its overexpression may promote tumor progression, including in bladder cancer.
TACC3 is crucial in cell division during mitosis. Mutations or overexpression of TACC3 have been found in various cancers, including bladder cancer.
Bladder cancer is the 10th most common cancer worldwide. There are many risk factors, with smoking being the most significant modifiable one. Bladder cancer has an excellent prognosis when diagnosed in its early stages.
Bladder cancer is the 10th most common cancer worldwide. There are many risk factors, with smoking being the most significant modifiable one. The other risk factors include being male, old age, exposure to carcinogens, consumption of alcohol and red meat, obesity, infections, etc. Bladder cancer typically presents with blood in the urine. Other symptoms like frequency of and pain during urination, or lower back pain, can also be present. In some cases, it can be asymptomatic. There are several examination methods available that can help with diagnosing bladder cancer. For example, cystoscopy, urinalysis, CT urogram, etc. The choice of treatment depends on several factors. You might prevent bladder cancer development by following some simple instructions: quit smoking, drink plenty of fluid, avoid carcinogens, alcohol, red meat, and consume a variety of fresh fruit and vegetables. The prognosis of bladder cancer is excellent when diagnosed at early stages.
Bladder cancer is the 10th most common cancer worldwide. In 2020, there were more than 500 thousand new cases. Greece has the highest prevalence of bladder cancer. It is mainly attributable to the high percentage of the smoking population. [1]
Several risk factors contribute to the development of the disease. These include:
Recent improvements in next-generation sequencing (NGS) technologies have largely helped scientists to understand the molecular processes happening during bladder cancer. Even though researchers suggest that positive family history among first-degree relatives might be a risk factor, results remain unclear. [16]
From the genomics point of view, the mechanisms leading to bladder cancer are often related to oncogene activation and overexpression, mutations in tumor suppressor genes, loss of gene repair function, various nucleotide abnormalities, or defects in the signaling pathways. [17]
Genetic changes (mutations) in certain genes, e.g. FGFR3, RB1, HRAS, TP53, or TSC1, are considered to be involved in tumor formation in the urinary bladder; these genes are important in cell division regulation.
Expression of the HER2 gene was examined in 354 patients and it was observed that in more than 32% of cases, the gene was highly expressed. Gene expression means that the genetic information (DNA) is copied to a molecule of mRNA (transcription, in the nucleus); these mRNA molecules are later transported to the cytoplasm, where the protein synthesis takes place (translation).
The cancer genome atlas (TCGA) studied genetic information (DNA) from 131 patients with muscle-invasive bladder cancer (MIBC), resulting in the identification of 32 affected genes. Furthermore, research of another TCGA group (composed of 412 MIBC patients) pointed out 58 mutated genes. Analysis of DNA methylation and gene expression was also performed, finding that 158 genes were epigenetically silenced (meaning gene expression is affected but there is no change in the DNA sequence). [17,18]
In Macromo, polygenic risk scores are used to determine the genetic risk. The polygenic risk score (PRS) is an estimate of the probability that an individual carries a given trait based on genetics, without considering environmental factors. Variants across their genome are summed and weighted according to their effect on the disease or trait.
Bladder cancer usually presents with nonspecific symptoms, but sometimes it can be asymptomatic. Other less severe medical conditions can present with the same symptoms.
Usually, the first sign at a presentation is hematuria - blood in the urine. In some cases, you can see it with the naked eye (gross hematuria). In other cases, it can be found only after a urine lab test (microscopic hematuria). [12]
Other symptoms include:
If cancer has spread to distant organs (metastasized), you can experience other symptoms depending on the affected organs.
If you experience any of the symptoms, consult with your GP. It is very likely caused by benign conditions like cystitis (bladder inflammation), but they should be treated anyway.
Your doctor can perform several tests to detect bladder cancer and learn more about it. However, not everyone will need all of the following examinations. [13] These include:
Additional imaging tests can be performed to determine if it has spread to distant organs. These include a CT scan, MRI, PET-CT, and ultrasound.
Several treatment options for bladder cancer are available. The method of choice depends on several factors. The stage of cancer, grade (how aggressive it is), type, and the patient's wishes contribute to selecting the right treatment option. [13]
The treatment options include:
You might be able to prevent bladder cancer by making some lifestyle modifications.
The 5-year survival rate means the percentage of people who survived for five years after the diagnosis. In general, the 5-year survival rate of bladder cancer is 77%. However, if it was diagnosed in the early stages, the 5-year survival rate is estimated to be much higher, 96%. [15]
Get the guidelines for a healthier and longer life. With Macromo tests, you'll learn your health risks and how to prevent them.
Continue to Shop[1] Bladder cancer statistics, (wcrf.org), https://www.wcrf.org/cancer-trends/bladder-cancer-statistics/#:~:text=bladder%20cancer%20data-,Bladder%20cancer%20is%20the%2010th%20most%20common%20cancer%20worldwide.,most%20common%20cancer%20in%20women.
[2] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7-34. doi:10.3322/caac.21551
[3] Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women [published correction appears in JAMA. 2011 Nov 23;306(20):2220]. JAMA. 2011;306(7):737-745. doi:10.1001/jama.2011.1142
[4] Zeegers MP, Swaen GM, Kant I, Goldbohm RA, van den Brandt PA. Occupational risk factors for male bladder cancer: results from a population based case cohort study in the Netherlands. Occup Environ Med. 2001;58(9):590-596. doi:10.1136/oem.58.9.590
[5] Marshall G, Ferreccio C, Yuan Y, et al. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst. 2007;99(12):920-928. doi:10.1093/jnci/djm004
[6] Zeegers MP, Volovics A, Dorant E, Goldbohm RA, van den Brandt PA. Alcohol consumption and bladder cancer risk: results from The Netherlands Cohort Study. Am J Epidemiol. 2001;153(1):38-41. doi:10.1093/aje/153.1.38
[7] Wang C, Jiang H. Meat intake and risk of bladder cancer: a meta-analysis. Med Oncol. 2012;29(2):848-855. doi:10.1007/s12032-011-9985-x
[8] Sun JW, Zhao LG, Yang Y, Ma X, Wang YY, Xiang YB. Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies. PLoS One. 2015;10(3):e0119313. Published 2015 Mar 24. doi:10.1371/journal.pone.0119313
[9] Inobaya MT, Olveda RM, Chau TN, Olveda DU, Ross AG. Prevention and control of schistosomiasis: a current perspective. Res Rep Trop Med. 2014;2014(5):65-75. doi:10.2147/RRTM.S44274
[10] Nesi G, Nobili S, Cai T, Caini S, Santi R. Chronic inflammation in urothelial bladder cancer. Virchows Arch. 2015;467(6):623-633. doi:10.1007/s00428-015-1820-x
[11] Chou WH, McGregor B, Schmidt A, et al. Cyclophosphamide-associated bladder cancers and considerations for survivorship care: A systematic review. Urol Oncol. 2021;39(10):678-685. doi:10.1016/j.urolonc.2021.05.017
[12] Bladder cancer: Symptoms & Signs, (cancer.net), https://www.cancer.net/cancer-types/bladder-cancer/symptoms-and-signs
[13] Bladder cancer: Diagnosis & Treatment, (mayoclinic.org), https://www.mayoclinic.org/diseases-conditions/bladder-cancer/diagnosis-treatment/drc-20356109
[14] Liu H, Wang XC, Hu GH, et al. Fruit and vegetable consumption and risk of bladder cancer: an updated meta-analysis of observational studies. Eur J Cancer Prev. 2015;24(6):508-516. doi:10.1097/CEJ.0000000000000119
[15] Bladder cancer: Statistics, (cacner.net), https://www.cancer.net/cancer-types/bladder-cancer/statistics#:~:text=The%20general%205%2Dyear%20survival,the%20bladder%20wall%20is%2096%25.
[16] Yu EYW, Stern MC, Jiang X, et al. Family History and Risk of Bladder Cancer: An Analysis Accounting for First- and Second-degree Relatives. Cancer Prev Res (Phila Pa). 2022;15(5):319-326. doi:10.1158/1940-6207.CAPR-21-0490
[17] Li Y, Sun L, Guo X, Mo N, Zhang J, Li C. Frontiers in Bladder Cancer Genomic Research. Front Oncol. 2021;11:670729. doi:10.3389/fonc.2021.670729
[18] Zhang X, Zhang Y. Bladder Cancer and Genetic Mutations. Cell Biochem Biophys. 2015;73(1):65-69. doi:10.1007/s12013-015-0574-z